EMA is holding the eight meeting of the Industry Standing Group (ISG). This forum for interaction has been established as part of the EMA's continuous improvement for engagement with industry stakeholders. It aims to:

The ISG is also discussing high level progress development updates of other topics of common interest for the Agency and the pharmaceutical industry (such as new fee regulations, EMA COVID lessons learned, European Medicines Agency Network activities update, international activities and cross-sectoral legislations and policies affecting EMA and medicines development etc).